Hong-Min Liu (Hongmin Liu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 40

Top Topics

High Efficiency

Structure Activity Relationship

Top Venues

Journal of medicinal chemistry

Medicinal research reviews

The journal of physical chemistry. B

Organic letters

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Shen, Bo Wang, Shao-Peng Wang, Shi-Kun Ji, Meng-Jie Fu, Shu-Wu Wang, Wen-Qing Hou, Xing-Jie Dai, Hong-Min Liu
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy. Journal of medicinal chemistry 67 (2) (2024)
Liang Shen, Bo Wang, Shao-Peng Wang, Shi-Kun Ji, Meng-Jie Fu, Shu-Wu Wang, Wen-Qing Hou, Xing-Jie Dai, Hong-Min Liu
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy. Journal of medicinal chemistry (2024)
Dan-Dan Shen, Yue-Lin Zhang, Xiang Li, Yi-Ru Bai, Jun-Feng Xiong, Dong-Jie Seng, Yao-Dong Zhang, Hong-Min Liu, Shuo Yuan, Li Yang
The mechanism of action and chemical synthesis of FDA newly approved drug molecules. Drug development research 85 (6) (2024)
Liang Shen, Bo Wang, Shao-Peng Wang, Shi-Kun Ji, Meng-Jie Fu, Shu-Wu Wang, Wen-Qing Hou, Xing-Jie Dai, Hong-Min Liu
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy. Journal of medicinal chemistry 67 (2) (2024)
Yi-Ru Bai, Wei-Guang Yang, Rui Jia, Ju-Shan Sun, Dan-Dan Shen, Hong-Min Liu, Shuo Yuan
The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancer. Medicinal research reviews (2024)
Liang Shen, Bo Wang, Shao-Peng Wang, Shi-Kun Ji, Meng-Jie Fu, Shu-Wu Wang, Wen-Qing Hou, Xing-Jie Dai, Hong-Min Liu
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy. Journal of medicinal chemistry 67 (2) (2024)
Kecheng Yang, Hong-Min Liu
Uncovering New Conformational States of the Substrate Binding Pocket of LSD1 Potential for Inhibitor Design via Funnel Metadynamics. The journal of physical chemistry. B 128 (1) (2023)
Xing-Jie Dai, Li-Juan Zhao, Long-Hua Yang, Ting Guo, Lei-Peng Xue, Hong-Mei Ren, Zhi-Li Yin, Xiao-Peng Xiong, Ying Zhou, Shi-Kun Ji, Hui-Min Liu, Hong-Min Liu, Ying Liu, Yi-Chao Zheng
Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells. Journal of medicinal chemistry (2023)
Kecheng Yang, Hong-Min Liu
Uncovering New Conformational States of the Substrate Binding Pocket of LSD1 Potential for Inhibitor Design via Funnel Metadynamics. The journal of physical chemistry. B 128 (1) (2023)
Kecheng Yang, Hong-Min Liu
Uncovering New Conformational States of the Substrate Binding Pocket of LSD1 Potential for Inhibitor Design via Funnel Metadynamics. The journal of physical chemistry. B 128 (1) (2023)
Hui-Min Liu, Ying Zhou, He-Xiang Chen, Jiang-Wan Wu, Shi-Kun Ji, Liang Shen, Shao-Peng Wang, Hong-Min Liu, Ying Liu, Xing-Jie Dai, Yi-Chao Zheng
LSD1 in drug discovery: From biological function to clinical application. Medicinal research reviews (2023)
Kecheng Yang, Hong-Min Liu
Uncovering New Conformational States of the Substrate Binding Pocket of LSD1 Potential for Inhibitor Design via Funnel Metadynamics. The journal of physical chemistry. B (2023)
Kun Zhang, Kaizhao Hu, Qian Li, Min Li, Ke Gao, Kecheng Yang, Bing Zhao, Xiao-Jing Shi, Lirong Zhang, Hong-Min Liu
Discovery of Novel 1,3-Diphenylpyrazine Derivatives as Potent S-Phase Kinase-Associated Protein 2 (Skp2) Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry (2023)
Xing-Jie Dai, Li-Juan Zhao, Long-Hua Yang, Ting Guo, Lei-Peng Xue, Hong-Mei Ren, Zhi-Li Yin, Xiao-Peng Xiong, Ying Zhou, Shi-Kun Ji, Hui-Min Liu, Hong-Min Liu, Ying Liu, Yi-Chao Zheng
Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells. Journal of medicinal chemistry 66 (6) (2023)
Kecheng Yang, Hong-Min Liu
Uncovering New Conformational States of the Substrate Binding Pocket of LSD1 Potential for Inhibitor Design via Funnel Metadynamics. The journal of physical chemistry. B 128 (1) (2023)
Shuo Yuan, Dan-Dan Shen, Rui Jia, Ju-Shan Sun, Jian Song, Hong-Min Liu
New drug approvals for 2022: Synthesis and clinical applications. Medicinal research reviews (2023)
Xing-Jie Dai, Li-Juan Zhao, Long-Hua Yang, Ting Guo, Lei-Peng Xue, Hong-Mei Ren, Zhi-Li Yin, Xiao-Peng Xiong, Ying Zhou, Shi-Kun Ji, Hui-Min Liu, Hong-Min Liu, Ying Liu, Yi-Chao Zheng
Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells. Journal of medicinal chemistry 66 (6) (2023)
Moges Dessale Asmamaw, Xiao-Jing Shi, Li-Rong Zhang, Hong-Min Liu
A comprehensive review of SHP2 and its role in cancer. Cellular oncology (Dordrecht) 45 (5) (2022)
Kai Tang, Le-Min Jiao, Yu-Ruo Qi, Tian-Ci Wang, Ya-Lan Li, Jia-Le Xu, Zi-Wei Wang, Bin Yu, Hong-Min Liu, Wen Zhao
Discovery of Novel Pyrazole-Based KDM5B Inhibitor TK - 129 and Its Protective Effects on Myocardial Remodeling and Fibrosis. Journal of medicinal chemistry 65 (19) (2022)
Xing-Jie Dai, Ying Liu, Xiao-Peng Xiong, Lei-Peng Xue, Yi-Chao Zheng, Hong-Min Liu
Correction to "Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective". Journal of medicinal chemistry 64 (9) (2021)
Li-Juan Zhao, Ying-Ying Li, Yu-Tong Zhang, Qi-Qi Fan, Hong-Mei Ren, Cheng Zhang, Adil Mardinglu, Wen-Chao Chen, Jing-Ru Pang, Dan-Dan Shen, Jun-Wei Wang, Long-Fei Zhao, Jian-Ying Zhang, Zhen-Ya Wang, Yi-Chao Zheng, Hong-Min Liu
Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness. EMBO reports 22 (8) (2021)
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Zi-Ning Lei, Zhe-Sheng Chen, Xiao-Bing Chen, Hong-Min Liu, Bin Yu
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance. Journal of medicinal chemistry 64 (21) (2021)
Xin-Hui Zhang, null Qin-Ma, Hui-Pan Wu, Mussa Yussuf Khamis, Yi-Han Li, Li-Ying Ma, Hong-Min Liu
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity. Journal of medicinal chemistry 64 (3) (2021)
Shuo Yuan, Jingya Zhang, Danqing Zhang, Dong-Hui Wei, Jiahui Zuo, Jian Song, Bin Yu, Hong-Min Liu
Cu(OTf)2-Catalyzed Intramolecular Radical Cascade Reactions for the Diversity-Oriented Synthesis of Quinoline-Annulated Polyheterocyclic Frameworks. Organic letters 23 (4) (2021)
Xing-Jie Dai, Ying Liu, Lei-Peng Xue, Xiao-Peng Xiong, Ying Zhou, Yi-Chao Zheng, Hong-Min Liu
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1. Journal of medicinal chemistry 64 (5) (2021)
Ling Fu, Bing-Kai Han, Fang-Feng Meng, Jun-Wei Wang, Tian-Ye Wang, Hui-Ju Li, Ying-Ying Sun, Guo-Na Zou, Xiao-Rui Li, Wen Li, Yue-Feng Bi, Yu Ke, Hong-Min Liu
Jaridon 6, a new diterpene from Rabdosia rubescens (Hemsl.) Hara, can display anti-gastric cancer resistance by inhibiting SIRT1 and inducing autophagy. Phytotherapy research : PTR 35 (10) (2021)
Shuo Yuan, Bo Wang, Qing-Qing Dai, Xiao-Nan Zhang, Jing-Ya Zhang, Jia-Hui Zuo, Hui Liu, Zhe-Sheng Chen, Guo-Bo Li, Shaomeng Wang, Hong-Min Liu, Bin Yu
Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors. Journal of medicinal chemistry 64 (19) (2021)
Clement Agboyibor, Jianshu Dong, Clement Yaw Effah, Emmanuel Kwateng Drokow, Waqar Pervaiz, Hong-Min Liu
LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor. Journal of oncology 2021 (2021)
Zhang-Xu He, Qi An, Bo Wei, Wen-Juan Zhou, Bing-Fei Wei, Yun-Peng Gong, Xin Zhang, Ge Gao, Guan-Jun Dong, Jin-Ling Huo, Xin-Hui Zhang, Fei-Fei Yang, Hong-Min Liu, Li-Ying Ma, Wen Zhao
Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects. Journal of medicinal chemistry 65 (1) (2021)
Xing-Jie Dai, Ying Liu, Lei-Peng Xue, Xiao-Peng Xiong, Ying Zhou, Yi-Chao Zheng, Hong-Min Liu
Correction to "Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1". Journal of medicinal chemistry 64 (9) (2021)
Hang Zhang, Haiwei Xu, Charles R Ashby, Yehuda G Assaraf, Zhe-Sheng Chen, Hong-Min Liu
Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Medicinal research reviews 41 (1) (2020)
Shuo Yuan, Dan-Qing Zhang, Jing-Ya Zhang, Bin Yu, Hong-Min Liu
Palladium-Catalyzed Ligand-Free Double Cyclization Reactions for the Synthesis of 3-(1'-Indolyl)-phthalides. Organic letters 22 (3) (2020)
Sixi Wang, Bin Yu, Hong-Min Liu
Pd(II)-Catalyzed Intramolecular C(sp2)-H Arylation of Tryptamines Using the Nonsteric NH2 as a Directing Group. Organic letters 23 (1) (2020)
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Linlin Yang, Zi-Ning Lei, Xiao-Han Yuan, Jun-Feng Huo, Xiao-Bing Chen, Mengru Wang, Bin Yu, Zhe-Sheng Chen, Hong-Min Liu
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. Journal of medicinal chemistry 63 (24) (2020)
Xing-Jie Dai, Ying Liu, Xiao-Peng Xiong, Lei-Peng Xue, Yi-Chao Zheng, Hong-Min Liu
Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective. Journal of medicinal chemistry 63 (23) (2020)
Moges Dessale Asmamaw, Ying Liu, Yi-Chao Zheng, Xiao-Jing Shi, Hong-Min Liu
Skp2 in the ubiquitin-proteasome system: A comprehensive review. Medicinal research reviews 40 (5) (2020)
Wen-Juan Zhou, Liying Ma, Lina Ding, Qian Guo, Zhangxu He, Jing Yang, Hui Qiao, Lingyu Li, Jie Yang, Shimin Yu, Lili Zhao, Shaomeng Wang, Hong-Min Liu, Zhenhe Suo, Wen Zhao
Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction. Journal of medicinal chemistry 63 (20) (2020)
Shuai Wang, Lijie Zhao, Xiao-Jing Shi, Lina Ding, Linlin Yang, Zhi-Zheng Wang, Dandan Shen, Kai Tang, Xiao-Jing Li, Maa Mamun, Huiju Li, Bin Yu, Yi-Chao Zheng, Shaomeng Wang, Hong-Min Liu
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction. Journal of medicinal chemistry 62 (5) (2019)
Wen-Juan Zhou, Liying Ma, Lina Ding, Qian Guo, Zhangxu He, Jing Yang, Hui Qiao, Lingyu Li, Jie Yang, Shimin Yu, Lili Zhao, Shaomeng Wang, Hong-Min Liu, Zhenhe Suo, Wen Zhao
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction. Journal of medicinal chemistry 62 (11) (2019)
Bo Wang, Li-Ying Ma, Jing-Quan Wang, Zi-Ning Lei, Pranav Gupta, Yuan-Di Zhao, Zhong-Hua Li, Ying Liu, Xin-Hui Zhang, Ya-Nan Li, Bing Zhao, Zhe-Sheng Chen, Hong-Min Liu
Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance. Journal of medicinal chemistry 61 (14) (2018)